Clinical Trial Update: Pharmacologic Modulation of Hippocampal Activity in Psychosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating pharmacologic modulation of hippocampal activity in schizophrenia/psychosis; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychosis
• Schizophrenia

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Schizophrenia; Psychosis | Phase 2 | Status: TERMINATED | Results posted: 2021-08-05